FDA Import Refusal 470-0004220-1/62/2 — PARKSLEY GLOBAL PRIVATE LIMITED
The FDA refused shipment 470-0004220-1/62/2 from PARKSLEY GLOBAL PRIVATE LIMITED (India) on Nov 24, 2025. The refused product falls under Drugs and Biologics — CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 24, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61FAB54 CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
- Charges
- 118,3280,75